A ready-made EL7 screen
CAN SLIM — O'Neil
25% EPS growth with top-quintile momentum near the 52-week high
The measurable parts of William O'Neil's CAN SLIM: quarterly EPS growth of 25%+, momentum in the market's top fifth, and a price within 15% of its 52-week high. Growth leaders in their phase of strength.
509 matching companies
What this screen asks for
EL7 factors
- Momentum80 or more
Financial ratios
- EPS growth YoY25% or more
- Distance from 52w high-15% or more
Matches
| Symbol | Company | Price | Change | EL7 Factor | Market cap |
|---|---|---|---|---|---|
| SLSSELLAS Life Sciences Group, Inc. | SELLAS Life Sciences Group, Inc. | 15.46 | +15.37% | 27 | 2.9B |
| MRVIMaravai LifeSciences Holdings, Inc. | Maravai LifeSciences Holdings, Inc. | 8.64 | +4.22% | 21 | 2.4B |
| CDNACareDx, Inc | CareDx, Inc | 48.61 | +3.45% | 97 | 2.5B |
| ELOXEloxx Pharmaceuticals, Inc. | Eloxx Pharmaceuticals, Inc. | 20.98 | +16.27% | 32 | 72.1M |
| ETONEton Pharmaceuticals, Inc. | Eton Pharmaceuticals, Inc. | 63.47 | +5.94% | 38 | 1.7B |
| DKDelek US Holdings, Inc. | Delek US Holdings, Inc. | 71.47 | +11.60% | 36 | 4.4B |
| RLYBRallybio Corporation | Rallybio Corporation | 16.83 | +1.39% | 39 | 89.3M |
| SYRESpyre Therapeutics, Inc. | Spyre Therapeutics, Inc. | 106.49 | −1.21% | 31 | 9.2B |
| VLOValero Energy Corporation | Valero Energy Corporation | 348.86 | +2.15% | 98 | 100.4B |
| TVTXTravere Therapeutics, Inc. | Travere Therapeutics, Inc. | 65.71 | +1.94% | 23 | 6.1B |
Showing 10 of 509
499 more companies match the same criteria and are available to subscribers.